{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:07:38Z","timestamp":1791148058759,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004486","name":"Fondazione Cassa di Risparmio di Perugia","doi-asserted-by":"publisher","award":["2013.0253.021 RICERCA SCIENTIFICA E TECNOLOGICA"],"award-info":[{"award-number":["2013.0253.021 RICERCA SCIENTIFICA E TECNOLOGICA"]}],"id":[{"id":"10.13039\/501100004486","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.autrev.2014.10.011","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T18:49:48Z","timestamp":1413312588000},"page":"117-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["GITR+ regulatory T cells in the treatment of autoimmune diseases"],"prefix":"10.1016","volume":"14","author":[{"given":"Maria Grazia","family":"Petrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ronchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Alunno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.10.011_bb0005","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.humimm.2011.12.012","article-title":"Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function","volume":"73","author":"Geiger","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0015","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1158\/0008-5472.CAN-05-4217","article-title":"Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25\u2212 lymphocytes is thymus and proliferation independent","volume":"66","author":"Valzasina","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2014.10.011_bb0020","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/neuonc\/nor134","article-title":"Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors","volume":"13","author":"Wainwright","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0030","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.autrev.2009.01.004","article-title":"Identification of regulatory T cells in systemic lupus erythematosus","volume":"8","author":"Gerli","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.10.011_bb0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2014.10.011_bb0040","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2014.10.011_bb0045","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0050","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","article-title":"Human FoxP3+ regulatory T cells in systemic autoimmune diseases","volume":"10","author":"Miyara","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.10.011_bb0055","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrrheum.2014.105","article-title":"TREG-cell therapies for autoimmune rheumatic diseases","volume":"10","author":"Miyara","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0060","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/rheumatology\/kel089","article-title":"Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood","volume":"45","author":"Lawson","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2014.10.011_bb0065","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10875-011-9542-6","article-title":"Combined treatment of etanercept and MTX reverses Th1\/Th2, Th17\/Treg imbalance in patients with rheumatoid arthritis","volume":"31","author":"Lina","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0070","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3346\/jkms.2012.27.9.1009","article-title":"Subpopulations of regulatory T cells in rheumatoid arthritis, systemic lupus erythematosus, and Behcet's disease","volume":"27","author":"Kim","year":"2012","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2014.10.011_bb0075","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.humimm.2013.08.003","article-title":"Altered Th17 cells and Th17\/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders","volume":"74","author":"Szodoray","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0080","first-page":"78","article-title":"Increased apoptosis induction in CD4+ CD25+ Foxp3+ T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation","volume":"18","author":"Li","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.autrev.2014.10.011_bb0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nm.3085","article-title":"Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis","volume":"19","author":"Nie","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2014.10.011_bb0090","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s13075-014-0444-x","article-title":"Expansion of regulatory GITR+CD25 Low\/-CD4+ T cells in systemic lupus erythematosus patients","volume":"16","author":"Nocentini","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.10.011_bb0095","doi-asserted-by":"crossref","first-page":"823085","DOI":"10.1155\/2012\/823085","article-title":"Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new","volume":"2012","author":"Alunno","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0100","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.178.4.2579","article-title":"Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus","volume":"178","author":"Valencia","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11892-012-0304-5","article-title":"Autologous regulatory T cells for the treatment of type 1 diabetes","volume":"12","author":"Thompson","year":"2012","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.autrev.2014.10.011_bb0110","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.2337\/db10-1661","article-title":"Uncoupling of proliferation and cytokines from suppression within the CD4+CD25+Foxp3+ T-cell compartment in the 1st year of human type 1 diabetes","volume":"60","author":"Hughson","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2014.10.011_bb0115","doi-asserted-by":"crossref","first-page":"e83811","DOI":"10.1371\/journal.pone.0083811","article-title":"Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients","volume":"8","author":"Cerosaletti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2014.10.011_bb0120","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/ncpneuro0832","article-title":"The role of regulatory T cells in multiple sclerosis","volume":"4","author":"Zozulya","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nm.3411","article-title":"Regulatory T cell proliferative potential is impaired in human autoimmune disease","volume":"20","author":"Carbone","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2014.10.011_bb0130","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.25429","article-title":"Regulatory T cells in tumor immunity","volume":"127","author":"Nishikawa","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.autrev.2014.10.011_bb0135","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2014.10.011_bb0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.coi.2011.12.011","article-title":"Modulation of GITR for cancer immunotherapy","volume":"24","author":"Schaer","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1479-5876-12-36","article-title":"Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs","volume":"12","author":"Lu","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2014.10.011_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coi.2014.01.001","article-title":"The immune contexture of primary and metastatic human tumours","volume":"27C","author":"Giraldo","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0155","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2337\/db11-1306","article-title":"Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice","volume":"61","author":"Yi","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2014.10.011_bb0160","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1096\/fj.04-3556com","article-title":"Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis","volume":"19","author":"Cuzzocrea","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2014.10.011_bb0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gut.2006.091181","article-title":"GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice","volume":"56","author":"Santucci","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2014.10.011_bb0170","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/eji.201141503","article-title":"Polyclonal Treg cells modulate T effector cell trafficking","volume":"41","author":"Davidson","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0175","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2014.10.011_bb0180","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2005-05-2183","article-title":"Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines","volume":"107","author":"Cannarile","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.10.011_bb0185","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.celrep.2014.03.004","article-title":"GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-beta signaling","volume":"7","author":"Bereshchenko","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2014.10.011_bb0190","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tips.2010.12.004","article-title":"FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents","volume":"32","author":"Ohkura","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.autrev.2014.10.011_bb0195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clim.2013.11.004","article-title":"Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology: is now the right time?","volume":"150","author":"Jethwa","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0200","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.10.011_bb0205","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.10.011_bb0210","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.coi.2011.06.006","article-title":"Regulatory T cells in stem cell transplantation: strategies and first clinical experiences","volume":"23","author":"Edinger","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","article-title":"First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127\u2212 T regulatory cells","volume":"133","author":"Trzonkowski","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fimmu.2014.00016","article-title":"Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells","volume":"5","author":"Bacchetta","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0225","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fimmu.2012.00030","article-title":"The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells","volume":"3","author":"Gregori","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0230","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2567.2012.03572.x","article-title":"Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers","volume":"136","author":"Himmel","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2014.10.011_bb0235","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.immuni.2007.11.021","article-title":"A two-step process for thymic regulatory T cell development","volume":"28","author":"Lio","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2014.10.011_bb0240","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.immuni.2007.11.022","article-title":"Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire","volume":"28","author":"Burchill","year":"2008","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.autrev.2014.10.011_bb0245","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/ni.2849","article-title":"Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells","volume":"15","author":"Mahmud","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0250","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood-2001-12-0276","article-title":"Role of GITR in activation response of T lymphocytes","volume":"100","author":"Ronchetti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.10.011_bb0255","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.4049\/jimmunol.173.8.5008","article-title":"Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells","volume":"173","author":"Stephens","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0260","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/eji.200636933","article-title":"GITR\/GITRL: more than an effector T cell co-stimulatory system","volume":"37","author":"Nocentini","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0265","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/eji.200324804","article-title":"GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations","volume":"34","author":"Ronchetti","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0270","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.4049\/jimmunol.0802751","article-title":"GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo","volume":"182","author":"van Olffen","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0275","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2011.10.014","article-title":"IFN-beta induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis","volume":"242","author":"Chen","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0280","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri2138","article-title":"Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans","volume":"7","author":"Roncarolo","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0285","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/eji.201142162","article-title":"Enhanced GITR\/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cells","volume":"42","author":"Carrier","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0290","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fimmu.2014.00035","article-title":"Glucocorticoid-induced TNF receptor family-related protein ligand is requisite for optimal functioning of regulatory CD4(+) T cells","volume":"5","author":"Liao","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0295","doi-asserted-by":"crossref","first-page":"e35981","DOI":"10.1371\/journal.pone.0035981","article-title":"Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent","volume":"7","author":"Feyler","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2014.10.011_bb0300","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1074-7613(02)00280-7","article-title":"CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor","volume":"16","author":"McHugh","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2014.10.011_bb0305","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni759","article-title":"Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance","volume":"3","author":"Shimizu","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0310","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4049\/jimmunol.168.3.1069","article-title":"Regulatory T cells overexpress a subset of Th2 gene transcripts","volume":"168","author":"Zelenika","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0315","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/978-0-387-89520-8_11","article-title":"GITR: a modulator of immune response and inflammation","volume":"647","author":"Nocentini","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0320","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0325","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4049\/jimmunol.171.2.708","article-title":"Regulation of murine inflammatory bowel disease by CD25+ and CD25\u2212CD4+ glucocorticoid-induced TNF receptor family-related gene+regulatory T cells","volume":"171","author":"Uraushihara","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0330","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.176.8.4748","article-title":"Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25\u2212 regulatory T cells","volume":"176","author":"Ono","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0335","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/bc400070q","article-title":"In vivo targeting of intratumor regulatory T cells using PEG-modified single-walled carbon nanotubes","volume":"24","author":"Sacchetti","year":"2013","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.autrev.2014.10.011_bb0340","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jnr.10766","article-title":"Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity","volume":"74","author":"Tsaknaridis","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.autrev.2014.10.011_bb0345","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.4049\/jimmunol.172.10.6435","article-title":"CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis","volume":"172","author":"de Kleer","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0350","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.4049\/jimmunol.173.5.3119","article-title":"CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells","volume":"173","author":"Makita","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0355","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2249.2004.02441.x","article-title":"Phenotypic characterization of regulatory T cells in the human decidua","volume":"136","author":"Heikkinen","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0360","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/eji.201242951","article-title":"Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor","volume":"43","author":"Benevides","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0365","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/hep.26013","article-title":"Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer","volume":"57","author":"Pedroza-Gonzalez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.10.011_bb0370","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jaci.2007.06.023","article-title":"Role of regulatory T cells and FOXP3 in human diseases","volume":"120","author":"Bacchetta","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0375","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.4049\/jimmunol.176.5.3215","article-title":"Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells","volume":"176","author":"Veldman","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0380","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20021139","article-title":"Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1T regulatory cells","volume":"196","author":"Levings","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2014.10.011_bb0385","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/eji.201040943","article-title":"CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity","volume":"41","author":"Bianchini","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0390","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.smim.2006.01.007","article-title":"Tr1 cells: from discovery to their clinical application","volume":"18","author":"Battaglia","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0395","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2014.10.011_bb0400","doi-asserted-by":"crossref","first-page":"361","DOI":"10.18388\/abp.2009_2469","article-title":"Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes","volume":"56","author":"Luczynski","year":"2009","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0405","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/intimm\/dxt020","article-title":"Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients","volume":"25","author":"Xufre","year":"2013","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0410","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1590\/0037-8682-0029-2013","article-title":"Glucocorticoid-induced tumor necrosis factor receptor expression in patients with cervical human papillomavirus infection","volume":"46","author":"Padovani","year":"2013","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.autrev.2014.10.011_bb0415","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/CBM-2010-0192","article-title":"Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa","volume":"7","author":"von Rahden","year":"2010","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.autrev.2014.10.011_bb0420","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/039463201202500108","article-title":"GITR-expressing regulatory T-cell subsets are increased in tumor-positive lymph nodes from advanced breast cancer patients as compared to tumor-negative lymph nodes","volume":"25","author":"Krausz","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0425","doi-asserted-by":"crossref","first-page":"e53903","DOI":"10.1371\/journal.pone.0053903","article-title":"Inherited variants in regulatory T cell genes and outcome of ovarian cancer","volume":"8","author":"Goode","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2014.10.011_bb0430","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2249.2011.04414.x","article-title":"Association of functional GITR gene polymorphisms related to expression of glucocorticoid-induced tumour necrosis factor-receptor (GITR) molecules with prognosis of autoimmune thyroid disease","volume":"165","author":"Tomizawa","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0435","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1055-9965.EPI-09-1151","article-title":"Risk of meningioma and common variation in genes related to innate immunity","volume":"19","author":"Rajaraman","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.autrev.2014.10.011_bb0440","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/rheumatology\/ket179","article-title":"Characterization of a new regulatory CD4+ T cell subset in primary Sjogren's syndrome","volume":"52","author":"Alunno","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2014.10.011_bb0445","first-page":"343","article-title":"Characterization of CD4+ and CD8+ Tregs in a Hodgkin's lymphoma patient presenting with myasthenia-like symptoms","volume":"66","author":"Krausz","year":"2013","journal-title":"Ideggyogy Sz"},{"key":"10.1016\/j.autrev.2014.10.011_bb0450","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1476-5381.2011.01753.x","article-title":"Pharmacological modulation of GITRL\/GITR system: therapeutic perspectives","volume":"165","author":"Nocentini","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0455","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2567.2009.03228.x","article-title":"Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibody","volume":"130","author":"Ponte","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2014.10.011_bb0460","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imlet.2008.09.003","article-title":"In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules","volume":"121","author":"Nishioka","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2014.10.011_bb0465","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/intimm\/dxq001","article-title":"GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells","volume":"22","author":"Liao","year":"2010","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0470","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-13-0086","article-title":"GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability","volume":"1","author":"Schaer","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.autrev.2014.10.011_bb0475","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.4049\/jimmunol.0802597","article-title":"Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand","volume":"183","author":"Wyzgol","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0480","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/cmi.2010.7","article-title":"An isoleucine-zipper motif enhances costimulation of human soluble trimeric GITR ligand","volume":"7","author":"Cui","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0485","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/CVI.00198-06","article-title":"Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro","volume":"13","author":"Stone","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0490","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/sj.cdd.4401140","article-title":"GITR interacts with the pro-apoptotic protein Siva and induces apoptosis","volume":"9","author":"Spinicelli","year":"2002","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.autrev.2014.10.011_bb0495","doi-asserted-by":"crossref","first-page":"15059","DOI":"10.1073\/pnas.2334901100","article-title":"Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells","volume":"100","author":"Tone","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2014.10.011_bb0500","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/eji.201343967","article-title":"Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412\/TAB08","volume":"44","author":"Tabares","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0505","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20130573","article-title":"Activating Fc gamma receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies","volume":"210","author":"Bulliard","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2014.10.011_bb0510","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1586\/17512433.2013.835698","article-title":"Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics","volume":"6","author":"De Groot","year":"2013","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0515","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0520","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.4049\/jimmunol.181.5.3285","article-title":"IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development","volume":"181","author":"Vang","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0525","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.coi.2009.05.007","article-title":"Plasticity of CD4(+) FoxP3(+) T cells","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0530","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1084\/jem.20050940","article-title":"Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells","volume":"202","author":"Ko","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2014.10.011_bb0535","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ni.1774","article-title":"Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo","volume":"10","author":"Zhou","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0540","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.4049\/jimmunol.178.11.6725","article-title":"Cutting edge: regulatory T cells induce CD4+CD25\u2212Foxp3\u2212 T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta","volume":"178","author":"Xu","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0545","doi-asserted-by":"crossref","first-page":"17100","DOI":"10.1074\/jbc.M111.316943","article-title":"Loss of T regulatory cell suppression following signaling through glucocorticoid-induced tumor necrosis receptor (GITR) is dependent on c-Jun N-terminal kinase activation","volume":"287","author":"Joetham","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2014.10.011_bb0550","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.4049\/jimmunol.1400604","article-title":"JNK2 regulates the functional plasticity of naturally occurring T regulatory cells and the enhancement of lung allergic responses","volume":"193","author":"Joetham","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0555","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","volume":"203","author":"Miyara","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2014.10.011_bb0560","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1007\/s10875-011-9559-x","article-title":"TRAIL is associated with impaired regulation of CD4+CD25\u2212 T cells by regulatory T cells in patients with rheumatoid arthritis","volume":"31","author":"Xiao","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0565","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s12020-009-9166-2","article-title":"Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis","volume":"35","author":"Alonso","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.autrev.2014.10.011_bb0570","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.4049\/jimmunol.1001860","article-title":"Cutting edge: increased IL-17-secreting T cells in children with new-onset type 1 diabetes","volume":"185","author":"Marwaha","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0575","doi-asserted-by":"crossref","first-page":"645643","DOI":"10.1155\/2011\/645643","article-title":"Lower frequency of CD62L(high) and higher frequency of TNFR2(+) Tregs are associated with inflammatory conditions in type 1 diabetic patients","volume":"2011","author":"Ryba","year":"2011","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2014.10.011_bb0580","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.humimm.2013.01.024","article-title":"Loss of the balance between CD4(+)Foxp3(+) regulatory T cells and CD4(+)IL17A(+) Th17 cells in patients with type 1 diabetes","volume":"74","author":"Ryba-Stanislawowska","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0585","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2013.06.007","article-title":"Biased Treg\/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms","volume":"262","author":"Jamshidian","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0590","first-page":"250","article-title":"Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(\u2212) regulatory T cells in multiple sclerosis","volume":"17","author":"Kouchaki","year":"2014","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.autrev.2014.10.011_bb0595","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.4049\/jimmunol.0904135","article-title":"Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease","volume":"186","author":"Mao","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0600","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/thy.2012.0514","article-title":"Impairment of regulatory T-cell function in autoimmune thyroid disease","volume":"23","author":"Glick","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2014.10.011_bb0605","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/08916934.2012.751981","article-title":"Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases","volume":"46","author":"Bossowski","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2014.10.011_bb0610","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s10620-008-0590-6","article-title":"Diminution of circulating CD4+CD25 high T cells in naive Crohn's disease","volume":"54","author":"Chamouard","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2014.10.011_bb0615","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2249.2009.03904.x","article-title":"The expression profile of functional regulatory T cells, CD4+CD25high+\/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease","volume":"156","author":"Kamikozuru","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0620","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.cyto.2011.06.021","article-title":"The CD4+CD28null and the regulatory CD4+CD25High T-cell phenotypes in patients with ulcerative colitis during active and quiescent disease, and following colectomy","volume":"56","author":"Yokoyama","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2014.10.011_bb0625","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1751-2980.2011.00505.x","article-title":"Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease","volume":"12","author":"Wang","year":"2011","journal-title":"J Dig Dis"},{"key":"10.1016\/j.autrev.2014.10.011_bb0630","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3109\/00365521.2011.551887","article-title":"Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients","volume":"46","author":"Reikvam","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2014.10.011_bb0635","doi-asserted-by":"crossref","first-page":"286368","DOI":"10.1155\/2013\/286368","article-title":"FOXP3(+) T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFalpha agents","volume":"2013","author":"Guidi","year":"2013","journal-title":"Biomed Res Int"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214002237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214002237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T22:23:29Z","timestamp":1717453409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214002237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":127,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1568997214002237"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.10.011","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GITR+ regulatory T cells in the treatment of autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}